Keap1-话题@MedSci

#Keap1#

5篇内容 | 891人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2123432, encodeId=5d45212343264, content=<a href='/topic/show?id=cb4c5e79c6' target=_blank style='color:#2F92EE;'>#DDRGK1#</a>在<a href='/topic/show?id=b85b10452af' target=_blank style='color:#2F92EE;'>#Keap1#</a>/<a href='/topic/show?id=7ee51303e38' target=_blank style='color:#2F92EE;'>#Nrf2#</a>/<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>途径中的关键作用，有助于推动<a href='/topic/show?id=251e10183059' target=_blank style='color:#2F92EE;'>#骨肉瘤#</a>治疗的研究和<a href='/topic/show?id=5c6f335e603' target=_blank style='color:#2F92EE;'>#化疗耐药#</a>性的克服, objectTitle=Advanced Science | 上海交通大学赵杰/秦安等合作发现骨肉瘤化疗耐药性的潜在新机制, objectType=article, longId=765359, objectId=ec35e6535921, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/diagnostic-form-in-hospital-conceptual-image-7JAH3GT.jpg, objectUrl=/article/show_article.do?id=ec35e6535921, replyNumber=0, likeNumber=66, createdTime=2023-04-03, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ec35e6535921, moduleTitle=Advanced Science | 上海交通大学赵杰/秦安等合作发现骨肉瘤化疗耐药性的潜在新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec35e6535921)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1595723, encodeId=1dc01595e23ce, content=<a href='/topic/show?id=b85b10452af' target=_blank style='color:#2F92EE;'>#Keap1#</a>, objectTitle=J Thorac Oncol：综合分析TP53和KEAP1突变在非小细胞肺癌(NSCLC)中的预后价值, objectType=article, longId=218079, objectId=d7002180e97d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7002180e97d, replyNumber=0, likeNumber=42, createdTime=2021-10-05, rootId=0, userName=villahu, userId=6c3a18296289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7002180e97d, moduleTitle=J Thorac Oncol：综合分析TP53和KEAP1突变在非小细胞肺癌(NSCLC)中的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7002180e97d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1595722, encodeId=464c1595e2277, content=<a href='/topic/show?id=b85b10452af' target=_blank style='color:#2F92EE;'>#Keap1#</a>, objectTitle=AACR 2020：STK11和KEAP1突变影响K药一线治疗PDL1阳性患者（Keynote 042研究）, objectType=article, longId=193109, objectId=bc64193109cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc64193109cc, replyNumber=0, likeNumber=37, createdTime=2020-04-30, rootId=0, userName=villahu, userId=6c3a18296289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc64193109cc, moduleTitle=AACR 2020：STK11和KEAP1突变影响K药一线治疗PDL1阳性患者（Keynote 042研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc64193109cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1595721, encodeId=e1b01595e2118, content=<a href='/topic/show?id=b85b10452af' target=_blank style='color:#2F92EE;'>#Keap1#</a>, objectTitle=CLIN CANCER RES：KEAP1和NFE2L2突变非小细胞肺癌临床病理特征, objectType=article, longId=142473, objectId=e52a1424e36d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e52a1424e36d, replyNumber=0, likeNumber=37, createdTime=2018-07-06, rootId=0, userName=villahu, userId=6c3a18296289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e52a1424e36d, moduleTitle=CLIN CANCER RES：KEAP1和NFE2L2突变非小细胞肺癌临床病理特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e52a1424e36d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1595720, encodeId=04e51595e2040, content=<a href='/topic/show?id=b85b10452af' target=_blank style='color:#2F92EE;'>#Keap1#</a>, objectTitle=p62–Keap1–Nrf2–Nqo1 信号通路可能与抗老化有关, objectType=article, longId=4051, objectId=79eb40516b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79eb40516b, replyNumber=0, likeNumber=33, createdTime=2012-02-19, rootId=0, userName=villahu, userId=6c3a18296289, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79eb40516b, moduleTitle=p62–Keap1–Nrf2–Nqo1 信号通路可能与抗老化有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79eb40516b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Keap1

2020-05-29

(审核中...)

前往app查看评论内容

#DDRGK1#在#Keap1#/#Nrf2#/#ROS#途径中的关键作用，有助于推动#骨肉瘤#治疗的研究和#化疗耐药#性的克服

Advanced Science | 上海交通大学赵杰/秦安等合作发现骨肉瘤化疗耐药性的潜在新机制

2023-04-03发表于上海

villahu (审核中...)

前往app查看评论内容

#Keap1#

J Thorac Oncol：综合分析TP53和KEAP1突变在非小细胞肺癌(NSCLC)中的预后价值

2021-10-05

villahu (审核中...)

前往app查看评论内容

#Keap1#

AACR 2020：STK11和KEAP1突变影响K药一线治疗PDL1阳性患者（Keynote 042研究）

2020-04-30

villahu (审核中...)

前往app查看评论内容

#Keap1#

CLIN CANCER RES：KEAP1和NFE2L2突变非小细胞肺癌临床病理特征

2018-07-06

villahu (审核中...)

前往app查看评论内容

#Keap1#

p62–Keap1–Nrf2–Nqo1 信号通路可能与抗老化有关

2012-02-19

科室
- - 订阅+
  - 更多科室
工具
服务